Bedair Elsayes Ali, Basura Alaa, Zahedi Farhad, Moreno-Duarte Ingrid, Rowin Ethan J, Maron Martin, Rastegar Hassan, Cobey Frederick C
Department of Anesthesiology and Perioperative Medicine, Tufts Medical Center, Boston, Massachusetts.
Department of Anesthesiology and Perioperative Medicine, Tufts Medical Center, Boston, Massachusetts; Department of Anesthesiology, Duke University Medical Center, Durham, North Carolina.
J Am Soc Echocardiogr. 2020 Feb;33(2):182-190. doi: 10.1016/j.echo.2019.08.021. Epub 2019 Nov 15.
Resolution of left ventricular outflow tract (LVOT) obstruction predicts symptom relief postmyectomy. Intraoperative measurement of LVOT gradients thus is essential for surgical guidance. We hypothesized that (1) hypertrophic cardiomyopathy patients have lower LVOT gradients when measured intraoperatively with transesophageal echocardiography (TEE) compared with preoperative measurements with transthoracic echocardiography (TTE) and that (2) intraoperative provocative testing can help evaluate the adequacy of surgical resection.
We compared resting LVOT gradients on preoperative TTE to intraoperative TEE. We also compared intraoperative resting and provoked gradients pre- and postresection. Either isoproterenol 10 μg/kg/min or dobutamine 20 μg/kg/min was used. Patients with provoked LVOT gradients >30 mm Hg were considered for further resection based on LVOT/mitral valve morphology and clinical comorbidities.
Of 315 patients identified, 293 patients were included in the analysis. There was a statistically significant difference between preoperative TTE and intraoperative TEE resting LVOT gradients (60.9 ± 39.4 mm Hg vs 42.0 ± 30.5 mm Hg, P < .0001). Out of 197 patients who had significant resting obstruction preoperatively, 82 (41.6%) demonstrated mild or no dynamic obstruction under general anesthesia. Provocative testing with both isoproterenol and dobutamine increased peak gradients (116.8 ± 33 mm Hg isoproterenol vs 107.5 ± 33 mm Hg dobutamine, P = .03). Post-cardiopulmonary bypass, seven patients (2.3%) had LVOT gradients > 30 mm Hg at rest, while 63 patients (21.5%) had residual gradients >30 mm Hg only with provocation. Elevated gradients, persistent systolic anterior motion of the mitral valve with near contact, and/or significant mitral regurgitation with provocative testing resulted in return to cardiopulmonary bypass in 41 patients (14%).
Resting intraoperative TEE LVOT gradients are significantly lower than preoperative TTE gradients, with systolic anterior motion of the MV and outflow obstruction often not visualized after inducing general anesthesia. Intraoperative pharmacologic provocation can identify patients who may benefit from further surgical intervention, facilitating procedural success.
左心室流出道(LVOT)梗阻的解除预示着心肌切除术后症状缓解。因此,术中测量LVOT梯度对于手术指导至关重要。我们假设:(1)与术前经胸超声心动图(TTE)测量相比,肥厚型心肌病患者术中经食管超声心动图(TEE)测量的LVOT梯度更低;(2)术中激发试验有助于评估手术切除的充分性。
我们比较了术前TTE时的静息LVOT梯度与术中TEE时的静息LVOT梯度。我们还比较了术中切除前后的静息和激发梯度。使用异丙肾上腺素10μg/kg/min或多巴酚丁胺20μg/kg/min。根据LVOT/二尖瓣形态和临床合并症,激发后LVOT梯度>30mmHg的患者考虑进一步切除。
在确定的315例患者中,293例患者纳入分析。术前TTE与术中TEE静息LVOT梯度之间存在统计学显著差异(60.9±39.4mmHg对42.0±30.5mmHg,P<.0001)。在术前静息梗阻明显的197例患者中,82例(41.6%)在全身麻醉下表现为轻度或无动态梗阻。异丙肾上腺素和多巴酚丁胺激发试验均增加了峰值梯度(异丙肾上腺素为116.8±33mmHg对多巴酚丁胺为107.5±33mmHg,P=.03)。体外循环后,7例患者(2.3%)静息时LVOT梯度>30mmHg,而63例患者(21.5%)仅在激发时存在残余梯度>30mmHg。激发试验时梯度升高、二尖瓣持续收缩期前移接近接触和/或明显二尖瓣反流导致41例患者(14%)返回体外循环。
术中TEE静息LVOT梯度显著低于术前TTE梯度,诱导全身麻醉后二尖瓣收缩期前移和流出道梗阻常不可见。术中药物激发可识别可能从进一步手术干预中获益的患者,促进手术成功。